Moon, Assad and Sun, Yuan and Wang, Yanjin and Huang, Jingshan and Zafar Khan, Muhammad Umar and Qiu, Hua-Ji (2022) Lactic Acid Bacteria as Mucosal Immunity Enhancers and Antivirals through Oral Delivery. Applied Microbiology, 2 (4). pp. 837-854. ISSN 2673-8007
applmicrobiol-02-00064.pdf - Published Version
Download (1MB)
Abstract
Mucosal vaccination offer an advantage over systemic inoculation from the immunological viewpoint. The development of an efficient vaccine is now a priority for emerging diseases such as COVID-19, that was declared a pandemic in 2020 and caused millions of deaths globally. Lactic acid bacteria (LAB) especially Lactobacillus are the vital microbiota of the gut, which is observed as having valuable effects on animals’ and human health. LAB produce lactic acid as the major by-product of carbohydrate degradation and play a significant role in innate immunity enhancement. LAB have significant characteristics to mimic pathogen infections and intrinsically possess adjuvant properties to enhance mucosal immunity. Increasing demand and deliberations are being substantially focused on probiotic organisms that can enhance mucosal immunity against viral diseases. LAB can also strengthen their host’s antiviral defense system by producing antiviral peptides, and releasing metabolites that prevent viral infections and adhesion to mucosal surfaces. From the perspectives of “one health” and the use of probiotics, conventional belief has opened up a new horizon on the use of LAB as antivirals. The major interest of this review is to depict the beneficial use of LAB as antivirals and mucosal immunity enhancers against viral diseases.
Item Type: | Article |
---|---|
Subjects: | Oalibrary Press > Biological Science |
Depositing User: | Managing Editor |
Date Deposited: | 03 Mar 2023 06:41 |
Last Modified: | 13 Mar 2024 04:20 |
URI: | http://asian.go4publish.com/id/eprint/439 |